The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fibroblast kinase 1-3 inhibitor BGJ398 in patients with FGFR1 amplified squamous non-small cell lung cancer treated in a phase I study: Evaluation of tumor tissue and response at a single center.
 
Lucia Nogova
Honoraria - Celgene; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer
 
Florian Malchers
Consulting or Advisory Role - NEO New Oncology
 
Elisabeth Bitter
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Sebastian Yves Friedrich Michels
Honoraria - AstraZeneca; Boehringer Ingelheim; Novartis; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
 
Rieke Nila Fischer
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - MSD
 
Matthias Scheffler
Consulting or Advisory Role - Boehringer Ingelheim; Novartis
 
Masyar Gardizi
No Relationships to Disclose
 
Vanessa Brandes
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; Novartis
 
Andreas H. Scheel
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
 
Karl-Otto Kambartel
No Relationships to Disclose
 
Stefan Krüger
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Monika Heidi Serke
Honoraria - Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
 
Randi Isaacs
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Dale Porter
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Reinhard Buettner
Consulting or Advisory Role - Targovax
Other Relationship - Targovax
 
Roman K. Thomas
Stock and Other Ownership Interests - New Oncology
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Clovis Oncology; Daiichi Sankyo; Johnson & Johnson; Lilly; Merck; MSD; Puma Biotechnology; Roche; Sanofi
Consulting or Advisory Role - New Oncology
Research Funding - AstraZeneca; EOS Biotechnology; Merck
 
Juergen Wolf
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; MSD; Novartis; Pfizer; Roche
Research Funding - MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)